Precision BioSciences (DTIL) has released an update.
Precision BioSciences, Inc. has completed a 1-for-30 reverse stock split on February 13, 2024, to reclassify every 30 shares of existing stock into a single share. This move was endorsed by stockholders and executed to adjust the exercise prices and underlying shares of the company’s equity awards and equity incentive plans. The stock will trade on a split-adjusted basis under the same symbol, with cash compensation for fractional shares based on the closing price before the split. This strategic decision aims to impact the company’s share price positively and maintain its Nasdaq listing requirements.
For further insights into DTIL stock, check out TipRanks’ Stock Analysis page.
